According to the WHO, 38 million individuals were living with human immunodeficiency virus
(HIV), 25.4 million of which were using antiretroviral therapy (ART) at the end of 2019 …

Although white AT can contribute to anti-infectious immune responses, it can also be
targeted and perturbed by pathogens. The AT's immune involvement is primarily due to …

Metabolic reprogramming is a hallmark of cancer and has proven to be critical in viral
infections. Metabolic reprogramming provides the cell with energy and biomass for large …

People living with HIV face a high risk of mental illness, especially depression. We do not yet
know the precise neurobiological mechanisms underlying HIV-associated depression …

HIV infection is associated with comorbidities that are likely to be driven not only by HIV
itself, but also by the toxicity of long-term use of antiretroviral therapy (ART). Indeed …

We have previously demonstrated mitochondrial dysfunction in aging CD4 T cells from
antiretroviral therapy (ART)-controlled people living with HIV (PLWH). However, the …

Financial incentives influence behavioural changes and the current review was done to
assess the effectiveness of this intervention in improving HIV care continuum. We conducted …

Chronic Human Immunodeficiency Virus (HIV) infection remains a significant challenge to
global public health. Despite advances in antiretroviral therapy (ART), which has …

HIV type 1 (HIV-1) is the causative agent of AIDS. Since the start of the epidemic, HIV/AIDS
has been responsible for≈ 40 million deaths. Additionally, an estimated 39 million people …

Commencing lifelong antiretroviral therapy (ART) immediately following HIV diagnosis
(Option B+) has dramatically improved the health of HIV-infected women and their children …